In breast cancer cells, resveratrol also increases the ATP2A3 expression through the promotion of the H3 lysine 27 acetylation into the ATP2A3 promoter, whereas it reduces methyl-DNA binding protein expression, such as MBD2 and MeCP2 [143]. The gene discussed is ATP2A3; the disease is breast carcinoma.